Discover a new way to find and share stories you'll loveā€¦ Learn about Reading Desk

Post Profile



Levaquin Approved For Treating Plague, USA

Levaquin (levofloxacin) has been approved by the FDA for the treatment and prevention of the plague. Levofloxacin is a synthetic antibiotic of the fluoroquinolones drug class; it is currently used for the treatment of severe bacterial infection, or infections for which other antibiotics have not worked. Levaquin is produced and marketed by Janssen Pharmaceuticals Inc., a Johnson & Johnson company.
read more

share

FDA Approves New Drug To Treat Severe Form Of Epilepsy

Health : Medical News Today (5 years ago)

The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome. "This approval offers another treatment option for... Read Post

FDA Approves First Generic Versions Of The Antibiotic Levofloxacin To Treat Certain Infections

Health : Medical News Today (3 years ago)

The U.S. Food and Drug Administration approved the first generic versions of Levaquin (levofloxacin), an antibiotic approved to treat certain infections in people ages 18 and older. Levofloxacin is used to treat mild, moderate, or s... Read Post

Generic Versions Of Antibiotic Levaquin (Levofloxacin) Approved By FDA

Health : Medical News Today (3 years ago)

The FDA has approved some generic version of Johnson & Johnson's Levaquin (levofloxacin), an antibiotic used to treat mild, moderate and severe bacterial infections for adult patients. The FDA (Food and Drug Administration) has appr... Read Post


Copyright © 2011 Regator, LLC